Literature DB >> 8653437

Inflammatory bronchopulmonary response of preterm infants with microbial colonisation of the airways at birth.

P Groneck1, B Goetze-Speer, C P Speer.   

Abstract

The inflammatory indicators in the tracheobronchial aspirate (TA) of 81 ventilated preterm infants with microbial colonisation of the airways and in non-colonised neonates were analysed on the first day of life. TA was assessed for chemotactic activity, neutrophil cell count, and concentrations of leukotriene B4, C5a, interleukin-1, interleukin-8, elastase-alpha 1-proteinase inhibitor, free elastase and albumin. Concentrations of mediators were related to concentrations of the secretory component of IgA. The infants' gestational age was mean (SD) 27.9 (2.0) weeks, birthweight 945 (179) g. In 12 infants (15%) microbial colonisation of the airways was present (Ureaplasma urealyticum n = 7; bacteria n = 5). Compared with non-colonised neonates (n = 69), chemotactic activity, neutrophil count, and concentrations of interleukin-1, leukotriene B4 and elastase-alpha 1-proteinase inhibitor were significantly higher in the colonised group. The difference was most pronounced for IL-1 concentrations, both with and without correction for secretory component. There was also a trend towards increased concentrations of interleukin-8 in the latter group. There were no differences for concentrations of C5a and albumin in the TA of both groups. It is concluded that airway colonisation with U urealyticum or bacteria at birth is associated with a clinically relevant bronchopulmonary inflammatory response. Increased concentrations of interleukin-1 in TA on the first day of life may be a marker of perinatal colonisation of the airways.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8653437      PMCID: PMC2528316          DOI: 10.1136/fn.74.1.f51

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  29 in total

1.  Elevation of fibronectin levels in lung secretions of infants with respiratory distress syndrome and development of bronchopulmonary dysplasia.

Authors:  C L Watts; A A Fanaroff; M C Bruce
Journal:  J Pediatr       Date:  1992-04       Impact factor: 4.406

2.  Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf.

Authors:  C P Speer; B Robertson; T Curstedt; H L Halliday; D Compagnone; O Gefeller; K Harms; E Herting; G McClure; M Reid
Journal:  Pediatrics       Date:  1992-01       Impact factor: 7.124

3.  Neonatal pneumonia.

Authors:  S Webber; A R Wilkinson; D Lindsell; P L Hope; S R Dobson; D Isaacs
Journal:  Arch Dis Child       Date:  1990-02       Impact factor: 3.791

4.  Increased levels of bronchoalveolar lavage fluid interleukin-6 in preterm ventilated infants after prolonged rupture of membranes.

Authors:  J M Grigg; A Barber; M Silverman
Journal:  Am Rev Respir Dis       Date:  1992-04

5.  Local production of interleukin-8 is associated with nosocomial pneumonia.

Authors:  J L Rodriguez; C G Miller; L E DeForge; L Kelty; C J Shanley; R H Bartlett; D G Remick
Journal:  J Trauma       Date:  1992-07

6.  Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections.

Authors:  R W Wilmott; J T Kassab; P L Kilian; W R Benjamin; S D Douglas; R E Wood
Journal:  Am Rev Respir Dis       Date:  1990-08

7.  Neutrophil elastase and acute pulmonary damage in neonates with severe respiratory distress syndrome.

Authors:  C P Speer; D Ruess; K Harms; E Herting; O Gefeller
Journal:  Pediatrics       Date:  1993-04       Impact factor: 7.124

8.  Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease.

Authors:  P Groneck; D Reuss; B Götze-Speer; C P Speer
Journal:  J Pediatr       Date:  1993-06       Impact factor: 4.406

9.  Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis.

Authors:  T Ozaki; H Hayashi; K Tani; F Ogushi; S Yasuoka; T Ogura
Journal:  Am Rev Respir Dis       Date:  1992-01

10.  Elastase alpha 1-proteinase inhibitor and lactoferrin concentrations in endotracheal aspirates of ventilated newborns.

Authors:  F K Tegtmeyer; S Maacks; W G Wood; W Wiebicke
Journal:  Pediatr Pulmonol       Date:  1992-06
View more
  14 in total

Review 1.  Can polyclonal intravenous immunoglobulin limit cytokine mediated cerebral damage and chronic lung disease in preterm infants?

Authors:  P V Mohan; W Tarnow-Mordi; B Stenson; P Brocklehurst; K Haque; V Cavendish; A Cust
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-01       Impact factor: 5.747

2.  Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants.

Authors:  B Jónsson; K Tullus; A Brauner; Y Lu; G Noack
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-11       Impact factor: 5.747

Review 3.  Can We Understand the Pathobiology of Bronchopulmonary Dysplasia?

Authors:  Cristina M Alvira; Rory E Morty
Journal:  J Pediatr       Date:  2017-11       Impact factor: 4.406

4.  Deficits in lung alveolarization and function after systemic maternal inflammation and neonatal hyperoxia exposure.

Authors:  Markus Velten; Kathryn M Heyob; Lynette K Rogers; Stephen E Welty
Journal:  J Appl Physiol (1985)       Date:  2010-03-11

5.  Role of ureaplasma urealyticum in lung disease of prematurity.

Authors:  K Hannaford; D A Todd; H Jeffery; E John; K Blyth; G L Gilbert
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-11       Impact factor: 5.747

6.  Randomised trial of erythromycin on the development of chronic lung disease in preterm infants.

Authors:  A J Lyon; J McColm; L Middlemist; S Fergusson; N McIntosh; P W Ross
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-01       Impact factor: 5.747

7.  Ureaplasma urealyticum modulates endotoxin-induced cytokine release by human monocytes derived from preterm and term newborns and adults.

Authors:  W M Manimtim; J D Hasday; L Hester; K D Fairchild; J C Lovchik; R M Viscardi
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

8.  Characterization of a murine model of Ureaplasma urealyticum pneumonia.

Authors:  Rose M Viscardi; Jennifer Kaplan; Judith C Lovchik; Ju Ren He; Lisa Hester; Srinivas Rao; Jeffrey D Hasday
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

Review 9.  Role of Ureaplasma species in neonatal chronic lung disease: epidemiologic and experimental evidence.

Authors:  Rose Marie Viscardi; Jeffrey D Hasday
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

10.  Relationship of proteinases and proteinase inhibitors with microbial presence in chronic lung disease of prematurity.

Authors:  Philip L Davies; O Brad Spiller; Michael L Beeton; Nicola C Maxwell; Eileen Remold-O'Donnell; Sailesh Kotecha
Journal:  Thorax       Date:  2010-03       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.